About Us

Nucleus Network has been Australia’s leading early phase clinical research organisation since establishment in 2003.

Nucleus Network is located at the AMREP Centre for Clinical Studies (an 80-bed early phase clinical trial unit co-located with the Alfred Medical Research Education Precinct at the Alfred Hospital).

Australia provides an expedited regulatory pathway, the CTN scheme, for the initiation of first-in-human clinical trials without the need for filing an IND.
Consequently, we primarily service a global client base.

We are a not-for-profit organisation, wholly owned by the Baker Heart and Diabetes Institute (the Baker Institute) , allowing reinvestment into the business to support quality clinical outcomes.